Trial · NCT00090103
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Four-Year Double-Blind Treatment Period | STARTED | Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg | 1,610 | |
| Four-Year Double-Blind Treatment Period | STARTED | Dutasteride 0.5 mg | 1,623 | |
| Four-Year Double-Blind Treatment Period | STARTED | Tamsulosin 0.4 mg | 1,611 | |
| Four-Year Double-Blind Treatment Period | COMPLETED | Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg | 1,113 | |
| Four-Year Double-Blind Treatment Period | COMPLETED | Dutasteride 0.5 mg | 1,093 | |
| Four-Year Double-Blind Treatment Period | COMPLETED | Tamsulosin 0.4 mg | 989 | |
| Four-Year Double-Blind Treatment Period | NOT COMPLETED | Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg | 497 | |
| Four-Year Double-Blind Treatment Period | NOT COMPLETED | Dutasteride 0.5 mg | 530 | |
| Four-Year Double-Blind Treatment Period | NOT COMPLETED | Tamsulosin 0.4 mg | 622 | |
| 16-Week Safety Follow-up Period | STARTED | Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg | 1,598 | |
| 16-Week Safety Follow-up Period | STARTED | Dutasteride 0.5 mg | 1,615 | |
| 16-Week Safety Follow-up Period | STARTED | Tamsulosin 0.4 mg | 1,600 | |
| 16-Week Safety Follow-up Period | COMPLETED | Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg | 1,224 | |
| 16-Week Safety Follow-up Period | COMPLETED | Dutasteride 0.5 mg | 1,205 | |
| 16-Week Safety Follow-up Period | COMPLETED | Tamsulosin 0.4 mg | 1,143 | |
| 16-Week Safety Follow-up Period | NOT COMPLETED | Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg | 374 | |
| 16-Week Safety Follow-up Period | NOT COMPLETED | Dutasteride 0.5 mg | 410 | |
| 16-Week Safety Follow-up Period | NOT COMPLETED | Tamsulosin 0.4 mg | 457 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00090103/flow